Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
BRIACELL THERAP (BCTX) had Cash Flow from Financial Activities of $3.95M for the most recently reported fiscal year, ending 2023-07-31.
| Income Statement Financials | |
-- |
|
$-20.30M |
|
-- |
|
-- |
|
$23.27M |
|
$-23.27M |
|
$2.97M |
|
$-20.30M |
|
$-20.30M |
|
$-20.30M |
|
$-20.30M |
|
$-20.30M |
|
$-20.30M |
|
$-23.27M |
|
$-23.26M |
|
15.62M |
|
15.62M |
|
$-1.30 |
|
$-1.30 |
|
| Balance Sheet Financials | |
$26.95M |
|
-- |
|
$0.22M |
|
$27.16M |
|
$1.80M |
|
-- |
|
$29.14M |
|
$30.94M |
|
$-3.78M |
|
$-3.99M |
|
$-3.78M |
|
15.98M |
|
| Cash Flow Statement Financials | |
$-23.74M |
|
-- |
|
|
Cash Flow from Financial Activities |
$3.95M |
$41.04M |
|
$21.25M |
|
$-19.79M |
|
$2.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
537.50% |
|
508.55% |
|
-74.74% |
|
537.50% |
|
$-0.24 |
|
$-1.52 |
|
$-1.52 |
|